mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

Vundavilli Jagadeesh Kumar

Author Profile
2
Publications
1
Years Active
9
Collaborators
40
Citations

Publications by Vundavilli Jagadeesh Kumar

2 publications found • Active 2018-2018

2018

2 publications

Validation of Stability-Indicating Reverse Phase HPLC Method for the Determination of Related Substances in Dapagliflozin Drug Substance

with Goutam Sen, K. Raghu Babu, N. Annapurna, N.A.Vekariya, K.S.R. Pavan Kumar 1 and Hemant Kumar Sharma
10/1/2018

A gradient reversed phase high performance liquid chromatography (RP-HPLC) method has been developed and validated for the determination for related substances of Dapagliflozin drug substance. Chromatographic separation of Dapagliflozin from its process and degradation related substances was achieved on YMC Pack Pro C18, 250mm × 4.6mm 5m i.e A stainless steel column 250 mm long, 4.6 mm internal diameter filled with Octadecyl silane chemically bonded to porous silica particles of 5 mm diameter maintained column oven temperature at 25°C. Orthophosphoric acid buffer is mobile phase A and acetonitrile is mobile phase B. Wavelength for UV detection: 225nm, flow rate: 0.8 ml/min and Injection volume: 20µl. The developed method suitability was checked and validated as per ICH guidelines for specificity, linearity, accuracy, precision, limit of quantification, limit of detection robustness and ruggedness experiments. Dapagliflozin drug substance was subjected to stress conditions of thermal, hydrolysis, humidity, peroxide and photolytic to observe the degradation products. Limit of detection of each RS is less than 0.008%w/w indicating that the developed method is highly sensitive. The experiment results are given in detailed in this research article.

Low Level Quantification of Potential Genotoxic Impurity In Ertapenem Monosodium Drug Substance by HPLC

with Vinay Kumar Patcha, Susheela Bhai Gajbhiye, U. K. Ray, K. S. R. Pavan Kumar 1 and N. Sreenivas
4/1/2018

A sensitive and rapid HPLC method developed and validated for the determination of potential genotoxic impurity namely m-aminobenzoic acid at trace level in Ertapenem monosodium by applying the concept of threshold of toxicological concern (TTC). The HPLC method was developed and optimized on Inertsil ODS-3V, 250 mm × 4.6 mm, 5mm column with oven temperature maintaining at 40°C. 0.02M Sodium Phosphate buffer pH 2.5 was chosen as mobile phase A and methanol was selected as mobile phase B in gradient reverse phase mode. Chromatographic parameters i.e flow rate: 1.0 ml/min, wavelength detection: 220 nm, injection volume: 10µl and run time: 20 min were applied in this methodology. Based on validation data, the method is found to be specific, sensitive, accurate and precise. The established limits of Limit of detection and Limit of quantification for this impurity are found to be 3.9 µg/g and 11.9 µg/g respectively.  The average recovery obtained was 99.8% at four levels in twelve determinations for m-aminobenzoic acid in Ertapenem monosodium drug substance. This method can be used as good quality control tool for quantization of m-aminobenzoic acid at low level. The experimental results are discussed in detail in this research paper.

Whatsapp